Information Provided By: 
Fly News Breaks for March 5, 2018
OFIX
Mar 5, 2018 | 06:30 EDT
SunTrust analyst Bruce Nudell raised his price target on Orthofix to $67 on modeled benefits of the company's effective corporate tax rate declining to about 30%. The analyst believes that the company will approach completion of its product portfolio refurbishment while also optimizing its sales footprint. Over the medium term, Nudell expects the company's bone stimulation business to grow at a mid-single digit range thanks to its strong insurance and sales infrastructure. The analyst keeps his Buy rating on Orthofix.
News For OFIX From the Last 2 Days
There are no results for your query OFIX
